US FDA Removes Clinical Hold on CEL-SCI's Phase 3 Head & Neck Cancer Trial - Business Wire (press release)

US FDA Removes Clinical Hold on CEL-SCI's Phase 3 Head & Neck Cancer Trial Business Wire (press release) Nine hundred twenty-eight (928) newly diagnosed head and neck cancer patients have been enrolled in this Phase 3 cancer study and all the patients who have completed treatment continue to be followed for protocol-specific outcomes in accordance with ... Ergomed Gets FDA Approval To Continue Phase 3 Study Of MultikineLondon South East (registration) (blog) all 2 news articles »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2wIPe75
via IFTTT